Ras-related protein Rab-27A
Ras-related protein Rab-27A (178-186) is a synthetic peptide fragment derived from the C-terminal region of the Rab27A protein, a member of the Rab family of small GTPases. Rab27A is recognized for its pivotal role in vesicle trafficking, exocytosis, and the regulation of intracellular membrane dynamics. The 178-186 peptide sequence represents a specific segment of the full-length protein, making it a valuable research tool for dissecting protein-protein interactions, post-translational modifications, and functional motifs within Rab27A. This peptide is particularly relevant in studies focused on vesicular transport mechanisms, secretory pathways, and the molecular underpinnings of Rab-mediated cellular processes.
Protein-protein interaction studies: The Rab-27A (178-186) peptide serves as a targeted probe for mapping interaction domains within the Rab27A protein and its binding partners. By employing this sequence in binding assays or pull-down experiments, researchers can elucidate the specific regions responsible for effector recognition and complex assembly. Such studies are instrumental in advancing the understanding of how Rab27A coordinates vesicle docking and fusion events, particularly in secretory cells.
Antibody production and epitope mapping: As an immunogenic peptide corresponding to a defined region of Rab27A, the 178-186 fragment is frequently used for generating sequence-specific antibodies. These antibodies enable precise detection and quantification of Rab27A in various cellular contexts. Additionally, the peptide is valuable for epitope mapping, allowing researchers to identify antibody binding sites, validate antibody specificity, and refine immunoassay design for both basic and applied research applications.
Post-translational modification analysis: The defined sequence of Rab-27A (178-186) is well suited for investigating post-translational modifications, such as phosphorylation or lipidation, that may occur within this region of the protein. Synthetic peptides like this one can be subjected to in vitro modification reactions, followed by mass spectrometry or other analytical techniques, to characterize modification patterns and their impact on protein function. These insights contribute to a deeper understanding of the regulatory mechanisms controlling Rab27A activity.
Functional assays in vesicle trafficking research: Incorporation of the Rab27A (178-186) peptide into functional studies enables the assessment of its role in vesicular transport and membrane trafficking. For instance, competition or inhibition assays using the peptide can help delineate the contribution of the C-terminal region to Rab27A-mediated processes, such as exosome release, lysosome-related organelle transport, or secretory granule dynamics. Such applications are critical for unraveling the molecular basis of intracellular transport pathways.
Peptide-based screening and inhibitor development: The defined structure of the Rab-27A (178-186) fragment provides a template for high-throughput screening of small molecules or peptide analogs that modulate Rab27A interactions. By serving as a reference sequence in binding assays, it aids in the identification and characterization of candidate inhibitors or modulators that target Rab27A-dependent pathways. This approach supports the development of research tools for probing vesicular trafficking and offers a platform for future studies aimed at regulating Rab-mediated cellular functions.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More